Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy
Sponsor: Horizon Health Network
Summary
The goal of this clinical trial is to learn if a non-opioid pain medicine regimen works as well as or better than a standard opioid-based regimen to manage pain during extracorporeal shockwave lithotripsy (ESWL) in adults. The main questions it aims to answer are: Does the non-opioid regimen lead to similar or better pain control during the procedure? Does the non-opioid regimen lead to similar or better procedure tolerability and side effect profile? The non-opioid regimen will use intravenous (IV) midazolam plus IV acetaminophen and IV ketorolac, and the standard opioid-based regimen will use IV midazolam plus IV fentanyl. Participants will be randomly assigned to receive one of the two medication regimens during ESWL, and asked to rate their pain before the procedure and 30 minutes after the procedure.
Official title: Intravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
266
Start Date
2026-03
Completion Date
2027-03
Last Updated
2026-01-28
Healthy Volunteers
No
Conditions
Interventions
IV midazolam
1-2 mg
IV fentanyl
25-300 mcg
IV acetaminophen
1 g
IV ketorolac
30 mg
Locations (1)
St. Joseph's Hospital
Saint John, New Brunswick, Canada